The Neuflo System is a new non-surgical, non-thermal, office-based prostate therapy being developed to treat BPH.
Prior to the Neuflo treatment, a mild oral sedative and antibiotic is recommended to be administered to limit patient anxiety and the risk of post-procedure infection. No nerve block or analgesic beyond a topical lidocaine gel has been shown necessary during the treatment in an international BPH feasibility study.
The urethra is prepared for catheter insertion by flushing the urethra with a lidocaine gel solution. Once the catheter has been routed to the bladder, the balloon at the tip of the catheter is inflated with saline. A trans-rectal ultrasound is recommended to verify that the balloon is properly inflated in the bladder and that it is properly seated in the bladder neck. The electrodes are extended and deployed prior to attachment to the control unit. This entire preparation process is expected to take less than 15 minutes.
The physician activates the treatment by pressing a button on the touch-screen display of the control unit. No repositioning of the catheter is anticipated and the treatment is designed to be delivered in less than 30 minutes.
At the conclusion of the treatment, the catheter is disconnected from the control unit, the electrodes retracted, and the catheter removed.